Regentis Biomaterials expanded its European clinical sites to boost patient recruitment and trial efficiency.

FDA fast-tracks two rapid tests for drug-resistant infections like MRSA and CRE.

Insulet's stock rose after beating Q4 2025 earnings expectations, driven by strong demand for its Omnipod insulin systems and higher revenue.

India launched LuSI, a 2.5 kg AI robot simulating newborn breathing, to improve neonatal care training and reduce infant deaths.

Aspire Biopharma regained Nasdaq compliance and avoids delisting after meeting equity requirements.

Dr. Reddy’s buys Progynova and Cyclo-Progynova brands from Mercury Pharma for $32.15M to enter India’s HRT market.

The 5th HOSPEX Healthcare Expo 2026 opens Feb 20 in Ahmedabad, India, showcasing medical tech innovations and attracting global visitors.

Medicare will now cover FDA-approved multicancer blood/saliva tests, boosting approval efforts despite cost and accuracy challenges.

Brazil and India plan joint drug production to cut costs and boost health security during Lula’s visit.

Merck's RSV antibody showed strong results in young children, supporting extended protection and FDA approval.